Analysts’ Updated EPS Estimates for April 1st (APLS, ASC, ASML, CML, CRM, INKT, LEVI, NKE, OEC, PHR)

Analysts’ updated eps estimates for Wednesday, April 1st:

Apellis Pharmaceuticals (NASDAQ:APLS) had its neutral rating reaffirmed by analysts at HC Wainwright. HC Wainwright currently has a $41.00 target price on the stock, down from their previous target price of $48.00.

Apellis Pharmaceuticals (NASDAQ:APLS) had its neutral rating reissued by analysts at Citigroup Inc.. The firm currently has a $41.00 target price on the stock, down from their previous target price of $44.00.

Apellis Pharmaceuticals (NASDAQ:APLS) had its market perform rating reiterated by analysts at Raymond James Financial, Inc..

ASOS (LON:ASC) had its buy rating reissued by analysts at Shore Capital Group Ltd. The firm currently has a GBX 216 price target on the stock.

ASML (NASDAQ:ASML) had its buy rating reissued by analysts at Barclays PLC.

CML Microsystems (LON:CML) had its house stock rating reaffirmed by analysts at Shore Capital Group Ltd. The firm currently has a GBX 223 price target on the stock.

Salesforce (NYSE:CRM) had its buy rating reaffirmed by analysts at BTIG Research. They currently have a $255.00 target price on the stock.

MiNK Therapeutics (NASDAQ:INKT) had its buy rating reissued by analysts at HC Wainwright. HC Wainwright currently has a $35.00 target price on the stock.

Levi Strauss & Co. (NYSE:LEVI) had its outperform rating reiterated by analysts at Telsey Advisory Group. Telsey Advisory Group currently has a $27.00 price target on the stock.

Macy’s (NYSE:M) had its market perform rating reaffirmed by analysts at Telsey Advisory Group. They currently have a $20.00 target price on the stock.

NIKE (NYSE:NKE) had its neutral rating reiterated by analysts at Bank of America Corporation. They currently have a $55.00 price target on the stock, down from their previous price target of $73.00.

NIKE (NYSE:NKE) had its neutral rating reaffirmed by analysts at JPMorgan Chase & Co.. They currently have a $52.00 target price on the stock.

NIKE (NYSE:NKE) had its neutral rating reiterated by analysts at The Goldman Sachs Group, Inc.. The Goldman Sachs Group, Inc. currently has a $52.00 target price on the stock.

Orion (NYSE:OEC) was downgraded by analysts at Wall Street Zen from a hold rating to a sell rating.

Phreesia (NYSE:PHR) had its market perform rating reissued by analysts at Citizens Jmp.

PPG Industries (NYSE:PPG) had its neutral rating reiterated by analysts at Citigroup Inc.. They currently have a $113.00 price target on the stock, down from their previous price target of $132.00.

PVH (NYSE:PVH) had its market perform rating reiterated by analysts at Telsey Advisory Group. Telsey Advisory Group currently has a $74.00 target price on the stock.

Renew (LON:RNWH) had its buy rating reaffirmed by analysts at Shore Capital Group Ltd. The firm currently has a GBX 850 price target on the stock.

Veracyte (NASDAQ:VCYT) had its buy rating reiterated by analysts at Needham & Company LLC. They currently have a $48.00 price target on the stock.

Value and Indexed Property Income (LON:VIP) had its house stock rating reissued by analysts at Shore Capital Group Ltd. They currently have a GBX 190 price target on the stock.

Weatherford International (NASDAQ:WFRD) was downgraded by analysts at Wall Street Zen from a strong-buy rating to a buy rating.

Receive News & Ratings for Apellis Pharmaceuticals Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apellis Pharmaceuticals Inc and related companies with MarketBeat.com's FREE daily email newsletter.